CME Group CME
$305.89 −$1.35 (-0.44%)
Market closed · Nov 6, 9:50 pm ET · Last extended-hours $305.89 0.00%
Open$303.68
Prev close$307.24
Day range$301.40 – $308.76
Volume1.45M
Market cap$109.49B
P/E (TTM)25.1
Dividend yield3.69%
Earnings
Average move on report day±1.8%last 16 reports
Closed higher10 of 1663% of the time
Best reaction+5.4%
Worst reaction-1.9%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 21 Oct 2026 | Pre Market | ±2.8% | +0.16% | Within range |
| 2026/Q2 | 22 Jul 2026 | Pre Market | ±3.9% | +5.00% | Bigger than priced |
| 2026/Q1 | 22 Apr 2026 | Pre Market | ±2.9% | +0.46% | Within range |
| 2025/Q4 | 4 Feb 2026 | Pre Market | ±3.0% | +0.53% | Within range |
| 2025/Q3 | 22 Oct 2025 | Pre Market | – | -0.30% | – |
| 2025/Q2 | 23 Jul 2025 | Pre Market | ±6.2% | +0.67% | Within range |
| 2025/Q1 | 23 Apr 2025 | Pre Market | ±5.4% | -1.54% | Within range |
| 2024/Q4 | 12 Feb 2025 | Pre Market | ±4.4% | +2.99% | Within range |
| 2024/Q3 | 23 Oct 2024 | Pre Market | ±4.9% | +0.43% | Within range |
| 2024/Q2 | 24 Jul 2024 | Pre Market | ±5.4% | -0.10% | Within range |
| 2024/Q1 | 24 Apr 2024 | Pre Market | ±3.5% | -1.93% | Within range |
| 2023/Q4 | 14 Feb 2024 | Pre Market | ±3.1% | +3.74% | Bigger than priced |
| 2023/Q3 | 25 Oct 2023 | Pre Market | ±2.9% | -0.08% | Within range |
| 2023/Q2 | 26 Jul 2023 | Pre Market | ±2.5% | +3.94% | Bigger than priced |
| 2023/Q1 | 26 Apr 2023 | Pre Market | ±2.9% | -1.52% | Within range |
| 2022/Q4 | 8 Feb 2023 | Pre Market | ±3.5% | +5.42% | Bigger than priced |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2026/Q3
By business line
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$1.74B+13.0% YoY
Operating profit$1.14B+17.4% YoY
Net profit$1.04B+14.2% YoY
Diluted EPS$2.89+16.1% YoY
Free cash flow$1.07B+12.7% YoY
Operating cash flow$1.09B
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin86.6%
Operating margin65.7%
Net margin63.1%
Return on equity16.1%
Return on assets2.3%
Return on invested capital14.7%
Current ratio1.02
Liabilities / assets86.2%
Cash & investments$2.33B
Total debt$3.43B
Net cash (debt)-$1.10B
Free cash flow / sales62.1%
No comments yet — be the first to weigh in on CME.
Sign in to join the discussion.